Fulgent Genetics, Inc.
FLGT- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001674930
In the last 90 days, Fulgent Genetics, Inc. insiders filed 0 open-market purchases and 4 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $321.8M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Fulgent Genetics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 180
- −15 vs. Q4 2023
- Shares held
- 14.8M
- +532.4K (+3.7%) vs. Q4 2023
- Total value
- $322.2M
- −$90.7M (−22.0%) vs. Q4 2023
- New holders
- 25
- 51 more added
- Sold out
- 40
- 62 more reduced
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FLGT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 141 | $321.8M |
| Q1 2026 | 158 | $277.7M |
| Q4 2025 | 179 | $468.9M |
| Q3 2025 | 163 | $389.3M |
| Q2 2025 | 168 | $323.2M |
| Q1 2025 | 177 | $275.8M |
| Q4 2024 | 189 | $314.3M |
| Q3 2024 | 183 | $349.6M |
| Q2 2024 | 174 | $299.6M |
| Q1 2024 | 180 | $322.2M |
| Q4 2023 | 197 | $413.6M |
| Q3 2023 | 201 | $380.5M |
| Q2 2023 | 214 | $514.8M |
| Q1 2023 | 216 | $422.8M |
| Q4 2022 | 224 | $391.2M |
| Q3 2022 | 235 | $506.9M |
| Q2 2022 | 263 | $710.8M |
| Q1 2022 | 275 | $758.4M |
| Q4 2021 | 299 | $1.13B |
| Q3 2021 | 269 | $1.02B |
| Q2 2021 | 254 | $986.4M |
| Q1 2021 | 256 | $973.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Fulgent Genetics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −8,265−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −8,118−100.0% | Sold out |
| Maryland State Retirement & Pension System | 0 | $0 | 0.00% | −7,496−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | – | Sold out |
| Asset Management One Co.,Ltd. | 0 | $0 | 0.00% | −2,039−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −416−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | −168−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Harbor Investment Advisory, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Caldwell Sutter Capital, Inc. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Security National Bank | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Putnam Investments LLC | – | – | – | – | Not filed |
| Nalls Sherbakoff Group, LLC | – | – | – | – | Not filed |